biologic medicines

Market Access

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline.

Patients

Dr Harold Keer, chief medical officer at Taiho Oncology, goes in-depth about why his company places such an emphasis on oral formulations.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.